TrialESMO open2026

Quality-of-life outcomes with pimitespib in patients with advanced gastrointestinal stromal tumor: results from the randomized, double-blind, placebo-controlled, phase III, CHAPTER-GIST-301 study.

Y Komatsu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.